Diffuse Skin Reaction in Patient with Hepatitis B, Treated with Two Different Formulations of Pegylated Interferon
Diffuse skin reactions, commonly leading to discontinuation of the treatment, have been reported in patients with hepatitis C treated with interferon. They were not as yet described in patients treated with a newer formulation of interferon, namely, pegylated interferon (PegINF). A 37-year-old male...
Saved in:
| Main Authors: | Piotr Milkiewicz, Colina Yim, Isabelle Pache, J Heathcote |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2005-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2005/298403 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pegylated Interferon Alpha for Chronic Hepatitis B Virus Infection
by: Joana Vasconcelos, et al.
Published: (2022-01-01) -
Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients
by: Konstantinos D. Pantazis, et al.
Published: (2008-01-01) -
Predictors of response to pegylated interferon treatment in HBeAg-negative patients with chronic hepatitis B
by: Ertugrul Guclu, et al.
Published: (2014-12-01) -
Sociocultural Factors That Potentially Affect the Institution of Prevention and Treatment Strategies for Hepatitis B in Chinese Canadians
by: Harry Wu, et al.
Published: (2009-01-01) -
Is Combined Bulevirtide and Pegylated Interferon Therapy for Chronic Hepatitis D Superior over Bulevirtide Monotherapy?
by: V. E. Syutkin, et al.
Published: (2020-09-01)